Header Logo

Connection

Patricia Boyle to Middle Aged

This is a "connection" page, showing publications Patricia Boyle has written about Middle Aged.
Connection Strength

1.344
  1. To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021 08 17; 144(7):2166-2175.
    View in: PubMed
    Score: 0.073
  2. Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia. Neurology. 2021 08 31; 97(9):e922-e929.
    View in: PubMed
    Score: 0.073
  3. Associations of health and financial literacy with mortality in advanced age. Aging Clin Exp Res. 2020 May; 32(5):951-957.
    View in: PubMed
    Score: 0.063
  4. Associations of literacy with diabetes indicators in older adults. J Epidemiol Community Health. 2019 03; 73(3):250-255.
    View in: PubMed
    Score: 0.061
  5. White matter correlates of temporal discounting in older adults. Brain Struct Funct. 2018 Nov; 223(8):3653-3663.
    View in: PubMed
    Score: 0.059
  6. Purpose in Life and Hospitalization for Ambulatory Care-Sensitive Conditions in Old Age. Am J Geriatr Psychiatry. 2018 03; 26(3):364-374.
    View in: PubMed
    Score: 0.055
  7. Cognitive decline impairs financial and health literacy among community-based older persons without dementia. Psychol Aging. 2013 Sep; 28(3):614-24.
    View in: PubMed
    Score: 0.042
  8. Poor decision making is a consequence of cognitive decline among older persons without Alzheimer's disease or mild cognitive impairment. PLoS One. 2012; 7(8):e43647.
    View in: PubMed
    Score: 0.039
  9. Cognitive function is associated with risk aversion in community-based older persons. BMC Geriatr. 2011 Sep 11; 11:53.
    View in: PubMed
    Score: 0.037
  10. Purpose in life is associated with a reduced risk of incident disability among community-dwelling older persons. Am J Geriatr Psychiatry. 2010 Dec; 18(12):1093-102.
    View in: PubMed
    Score: 0.035
  11. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology. 2010; 34(1):43-9.
    View in: PubMed
    Score: 0.032
  12. Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol. 2009 Nov; 66(11):1339-44.
    View in: PubMed
    Score: 0.032
  13. Lower extremity motor function and disability in mild cognitive impairment. Exp Aging Res. 2007 Jul-Sep; 33(3):355-71.
    View in: PubMed
    Score: 0.028
  14. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007 Mar; 18(3):581-92.
    View in: PubMed
    Score: 0.027
  15. Parkinsonian signs in subjects with mild cognitive impairment. Neurology. 2005 Dec 27; 65(12):1901-6.
    View in: PubMed
    Score: 0.025
  16. Subjective appraisal of Alzheimer's disease caregiving: the role of self-efficacy and depressive symptoms in the experience of burden. Am J Alzheimers Dis Other Demen. 2005 Sep-Oct; 20(5):273-80.
    View in: PubMed
    Score: 0.024
  17. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005 Mar; 16(3):481-8.
    View in: PubMed
    Score: 0.023
  18. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol. 2004 May; 45(5):620-6; discussion 626-7.
    View in: PubMed
    Score: 0.022
  19. The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study. BJU Int. 2003 Nov; 92(7):719-25.
    View in: PubMed
    Score: 0.021
  20. The relationship between lower urinary tract symptoms and health status: the UREPIK study. BJU Int. 2003 Oct; 92(6):575-80.
    View in: PubMed
    Score: 0.021
  21. The importance of benign urological disease in communities. BJU Int. 2003 Sep; 92(4):342-3.
    View in: PubMed
    Score: 0.021
  22. Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? Ann Oncol. 2003 Aug; 14(8):1312-25.
    View in: PubMed
    Score: 0.021
  23. Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol. 2003 Jul; 14(7):1148-52.
    View in: PubMed
    Score: 0.021
  24. Cognitive and neurologic predictors of functional impairment in vascular dementia. Am J Geriatr Psychiatry. 2003 Jan-Feb; 11(1):103-6.
    View in: PubMed
    Score: 0.020
  25. Cognitive and motor impairments predict functional declines in patients with vascular dementia. Int J Geriatr Psychiatry. 2002 Feb; 17(2):164-9.
    View in: PubMed
    Score: 0.019
  26. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999 Jul 10; 354(9173):93-9.
    View in: PubMed
    Score: 0.016
  27. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019 06 01; 142(6):1503-1527.
    View in: PubMed
    Score: 0.016
  28. Age-period-cohort analysis of chronic disease rates. I: Modelling approach. Stat Med. 1998 Jun 30; 17(12):1305-23.
    View in: PubMed
    Score: 0.015
  29. Age-period-cohort models of chronic disease rates. II: Graphical approaches. Stat Med. 1998 Jun 30; 17(12):1325-39.
    View in: PubMed
    Score: 0.015
  30. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2018 05 29; 9(1):2098.
    View in: PubMed
    Score: 0.015
  31. Are cancers of the salivary gland increasing? Experience from Connecticut, USA. Int J Epidemiol. 1997 Apr; 26(2):264-71.
    View in: PubMed
    Score: 0.014
  32. CLARION patient performance: an update on the adult and children's clinical trials. Scand Audiol Suppl. 1997; 47:45-9.
    View in: PubMed
    Score: 0.013
  33. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935-1992. Int J Cancer. 1996 Aug 07; 67(4):504-9.
    View in: PubMed
    Score: 0.013
  34. The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int J Epidemiol. 1996 Apr; 25(2):252-8.
    View in: PubMed
    Score: 0.013
  35. Late-life depression is not associated with dementia-related pathology. Neuropsychology. 2016 Feb; 30(2):135-42.
    View in: PubMed
    Score: 0.012
  36. Mild Cognitive Impairment and Susceptibility to Scams in Old Age. J Alzheimers Dis. 2016; 49(3):845-51.
    View in: PubMed
    Score: 0.012
  37. Determinants of treatment-seeking behaviour for urinary symptoms in older men. Br J Urol. 1995 Dec; 76(6):714-8.
    View in: PubMed
    Score: 0.012
  38. Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology. 2015 Sep 15; 85(11):984-91.
    View in: PubMed
    Score: 0.012
  39. Poorer Financial and Health Literacy Among Community-Dwelling Older Adults With Mild Cognitive Impairment. J Aging Health. 2015 Sep; 27(6):1105-17.
    View in: PubMed
    Score: 0.012
  40. Conscientiousness, dementia related pathology, and trajectories of cognitive aging. Psychol Aging. 2015 Mar; 30(1):74-82.
    View in: PubMed
    Score: 0.012
  41. Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
    View in: PubMed
    Score: 0.012
  42. Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology. 2014 Aug 19; 83(8):702-9.
    View in: PubMed
    Score: 0.011
  43. Financial literacy is associated with medial brain region functional connectivity in old age. Arch Gerontol Geriatr. 2014 Sep-Oct; 59(2):429-38.
    View in: PubMed
    Score: 0.011
  44. Perinatal and early postnatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer. 1994 Jan 02; 56(1):11-5.
    View in: PubMed
    Score: 0.011
  45. Antenatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer. 1994 Jan 02; 56(1):6-10.
    View in: PubMed
    Score: 0.011
  46. Correlates of susceptibility to scams in older adults without dementia. J Elder Abuse Negl. 2014; 26(2):107-22.
    View in: PubMed
    Score: 0.011
  47. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 2013 Nov; 70(11):1418-24.
    View in: PubMed
    Score: 0.011
  48. Ventromedial PFC, parahippocampal, and cerebellar connectivity are associated with temporal discounting in old age. Exp Gerontol. 2013 Dec; 48(12):1489-98.
    View in: PubMed
    Score: 0.011
  49. Total daily activity declines more rapidly with increasing age in older adults. Arch Gerontol Geriatr. 2014 Jan-Feb; 58(1):74-9.
    View in: PubMed
    Score: 0.011
  50. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
    View in: PubMed
    Score: 0.010
  51. Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology. 2013 Mar 26; 80(13):1202-8.
    View in: PubMed
    Score: 0.010
  52. Risk factors for gallbladder cancer: a Polish case-control study. Int J Cancer. 1992 Jul 09; 51(5):707-11.
    View in: PubMed
    Score: 0.010
  53. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011 Mar; 68(3):351-6.
    View in: PubMed
    Score: 0.009
  54. Alcohol, beer and cancer of the pancreas. Int J Cancer. 1990 May 15; 45(5):842-6.
    View in: PubMed
    Score: 0.008
  55. The application of age, period and cohort models to predict Swiss cancer mortality. J Cancer Res Clin Oncol. 1990; 116(2):207-14.
    View in: PubMed
    Score: 0.008
  56. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol. 2010 Jun; 21(6):1323-1360.
    View in: PubMed
    Score: 0.008
  57. Association between late-life social activity and motor decline in older adults. Arch Intern Med. 2009 Jun 22; 169(12):1139-46.
    View in: PubMed
    Score: 0.008
  58. Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study. Heart. 2008 Sep; 94(9):1141-6.
    View in: PubMed
    Score: 0.007
  59. Statistical modelling of lung cancer and laryngeal cancer incidence in Scotland, 1960-1979. Am J Epidemiol. 1987 Apr; 125(4):731-44.
    View in: PubMed
    Score: 0.007
  60. Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitor. BJU Int. 2003 Aug; 92(3):262-6.
    View in: PubMed
    Score: 0.005
  61. Mortality from major cancer sites in the European Union, 1955-1998. Ann Oncol. 2003 Mar; 14(3):490-5.
    View in: PubMed
    Score: 0.005
  62. The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients. Am J Geriatr Psychiatry. 2002 Jan-Feb; 10(1):107-11.
    View in: PubMed
    Score: 0.005
  63. A case-control study of lung cancer among Czech women. Lung Cancer. 2001 Feb-Mar; 31(2-3):111-22.
    View in: PubMed
    Score: 0.004
  64. Lung cancer incidence rates by histologic type: an example of trends in Eastern Europe--Slovakia 1978-95. Neoplasma. 2001; 48(4):247-53.
    View in: PubMed
    Score: 0.004
  65. [Prevalence of lower urinary tract symptoms in men and its influence on their quality of life: Boxmeer Study]. Ned Tijdschr Geneeskd. 2000 Dec 30; 144(53):2558-63.
    View in: PubMed
    Score: 0.004
  66. A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev. 2000; 24(4):305-13.
    View in: PubMed
    Score: 0.004
  67. Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Inst. 1998 Mar 04; 90(5):389-94.
    View in: PubMed
    Score: 0.004
  68. Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989. Cancer. 1994 Sep 01; 74(5):1556-67.
    View in: PubMed
    Score: 0.003
  69. Trends of oral cancer mortality among females worldwide. Cancer Causes Control. 1994 May; 5(3):255-8.
    View in: PubMed
    Score: 0.003
  70. Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control. 1994 May; 5(3):259-65.
    View in: PubMed
    Score: 0.003
  71. Epidemiological aspects of lip cancer in Scotland. Community Dent Oral Epidemiol. 1993 Oct; 21(5):279-82.
    View in: PubMed
    Score: 0.003
  72. Oral cancer in Scotland: changing incidence and mortality. BMJ. 1992 Nov 07; 305(6862):1121-3.
    View in: PubMed
    Score: 0.002
  73. Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89. Cancer Causes Control. 1992 Sep; 3(5):481-92.
    View in: PubMed
    Score: 0.002
  74. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988. Cancer. 1992 Aug 15; 70(4):840-9.
    View in: PubMed
    Score: 0.002
  75. Trends of cancer mortality in Europe, 1955-1989: II, Respiratory tract, bone, connective and soft tissue sarcomas, and skin. Eur J Cancer. 1992; 28(2-3):514-99.
    View in: PubMed
    Score: 0.002
  76. Descriptive epidemiology of Hodgkin's disease in Italy. Tumori. 1989 Oct 31; 75(5):401-5.
    View in: PubMed
    Score: 0.002
  77. Risk factors and prognosis in primary biliary cirrhosis. Am J Gastroenterol. 1989 Jul; 84(7):713-6.
    View in: PubMed
    Score: 0.002
  78. Metolazone and bendroflumethiazide in hypertension: physiologic and metabolic observations. Clin Pharmacol Ther. 1980 Nov; 28(5):611-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.